Late-breaking research results for acute lymphoblastic leukemia (ALL) Isra Zaman14 Dec 2022 9:15 AM ISTAcute lymphocytic leukemia (ALL) is a kind of blood and bone marrow malignancy. Blood cells are generated in the spongy tissue inside the bones....
Novel drug shows early promise in treating multiple myeloma Dr. Kamal Kant Kohli12 Dec 2022 8:00 PM IST A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a...
Medical Bulletin 7/November/2022 Isra Zaman7 Nov 2022 4:00 PM ISTHere are the top medical news for the day:Therapies identified for patients whose blood cancer relapses after CAR-TCAR-T, short for chimeric antigen...
Therapies identified for patients whose blood cancer relapses after CAR-T Isra Zaman7 Nov 2022 9:15 AM ISTCAR-T, short for chimeric antigen receptor T-cell therapy, enlists immune cells called T cells to fight multiple myeloma by altering them in the lab...
USFDA approves Kite retroviral vector manufacturing facility in Southern California for commercial production Ruchika Sharma5 Oct 2022 12:52 PM ISTThe Oceanside site is part of Kite’s global commercial manufacturing network that includes facilities in El Segundo, California, Amsterdam,...
New research may help generate production of blood platelets on demand Dr. Kamal Kant Kohli27 Sept 2022 6:45 AM ISTIncreasing shortages of donor-derived platelet units has promoted researchers to explore alternative methods of meeting with shortage including cell...
Gilead Sciences' Kite gets European Commission nod for CAR T-cell therapy Tecartus Ruchika Sharma8 Sept 2022 4:00 PM ISTSanta Monica, Calif.: Kite, a Gilead Company has announced that the European Commission (EC) has approved its CAR T-cell therapy Tecartus...
Lupin rationalising product portfolio in US to overcome price erosion impact, says CEO Vinita Gupta Ruchika Sharma16 Aug 2022 1:30 PM ISTLupin's transitioning of the portfolio from the simple generic oral solids to complex generics had started with short-acting bronchodilator albuterol.
Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine Dr. Kamal Kant Kohli13 July 2022 8:30 PM ISTPeople with hematologic malignancies-or blood cancers including leukemia, lymphoma, and multiple myeloma-have an impaired immune system due to their...
Roche gets USFDA priority review for Lunsumio to treat relapsed or refractory follicular lymphoma Ruchika Sharma8 July 2022 5:30 PM ISTPriority Review designation is granted to medicines that the FDA considers to have the potential to provide significant improvements in the safety and...
AstraZeneca broadens haematological cancer pipeline with TeneoTwo acquisition Ruchika Sharma6 July 2022 12:30 PM ISTAstraZeneca will acquire all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m on deal closing.
Adult survivors of childhood cancer often undertreated for cardiovascular risk factors Dr. Kamal Kant Kohli28 Jun 2022 4:45 AM ISTDALLAS: Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to...
